Genetic variation in NDFIP1 modifies the metabolic patterns in immune cells of multiple sclerosis patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 11 2021
Historique:
received: 09 06 2021
accepted: 08 10 2021
entrez: 2 11 2021
pubmed: 3 11 2021
medline: 27 1 2022
Statut: epublish

Résumé

One of the 233 polymorphisms associated with multiple sclerosis (MS) susceptibility lies within the NDFIP1 gene, and it was previously identified as eQTL in healthy controls. NDFIP1 shows interesting immune functions and is involved in the development of the central nervous system. We aimed at studying the NDFIP1 variant on activation and metabolism of immune cells. NDFIP1 mRNA and protein expression were assessed in PBMCs by qPCR and western blot in 87 MS patients and 84 healthy controls genotyped for rs4912622. Immune activation after PHA stimulation was evaluated by CD69 upregulation, and metabolic function of both basal and PHA-activated lymphocytes was studied by Seahorse Xfp-Analyzer. In minor-allele homozygous controls but not in patients, we found higher NDFIP1 expression, significantly reduced protein levels, and CD69 upregulation in B- and T-cells. PBMCs from minor-allele homozygous controls showed significantly higher basal mitochondrial respiration and ATP production compared to major-allele carriers, while minor-allele homozygous patients showed significantly lower metabolic activity than carriers of the major allele. In conclusion, we describe associations in minor-allele homozygous controls with lower levels of NDFIP1 protein, CD69 upregulation, and raised mitochondrial activity, which are not replicated in MS patients, suggesting a NDFIP1 differential effect in health and disease.

Identifiants

pubmed: 34725369
doi: 10.1038/s41598-021-00528-8
pii: 10.1038/s41598-021-00528-8
pmc: PMC8560952
doi:

Substances chimiques

Carrier Proteins 0
Membrane Proteins 0
NDFIP1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21371

Subventions

Organisme : Promoción de empleo joven y garantía juvenil-CAM
ID : PEJ-3-2019
Organisme : Promoción de empleo joven y garantía juvenil-CAM
ID : PEJD-2019-PRE/SAL-16662
Organisme : Instituto de Salud Carlos III
ID : RETICS-REEM RD16/0015/0013

Informations de copyright

© 2021. The Author(s).

Références

Virol J. 2010 Aug 03;7:179
pubmed: 20682038
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21931-6
pubmed: 21106759
Nat Genet. 2013 Nov;45(11):1353-60
pubmed: 24076602
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2067-74
pubmed: 24520172
Eur J Immunol. 2015 Feb;45(2):344-55
pubmed: 25378177
Science. 2014 Mar 7;343(6175):1246980
pubmed: 24604203
Mol Biosyst. 2009 Dec;5(12):1512-26
pubmed: 20023718
Mult Scler Relat Disord. 2021 Jan;47:102633
pubmed: 33254090
Science. 2019 Sep 27;365(6460):
pubmed: 31604244
Nat Genet. 2010 Dec;42(12):1118-25
pubmed: 21102463
Nat Commun. 2017 Jun 05;8:15677
pubmed: 28580955
Immunol Rev. 2014 May;259(1):231-44
pubmed: 24712469
Nature. 2020 Jul;583(7818):711-719
pubmed: 32728246
Ment Health Clin. 2018 Mar 23;7(5):213-220
pubmed: 29955526
Nat Rev Neurol. 2017 Jan;13(1):25-36
pubmed: 27934854
J Clin Invest. 2015 Jan;125(1):194-207
pubmed: 25437876
Cell Death Dis. 2018 Sep 5;9(9):905
pubmed: 30185773
Front Genet. 2018 Feb 14;9:29
pubmed: 29491882
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Trends Mol Med. 2013 Oct;19(10):625-32
pubmed: 23954168
Nat Genet. 2018 Jan;50(1):4-5
pubmed: 29273804
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nat Immunol. 2016 Dec;17(12):1459-1466
pubmed: 27695003
Rheumatology (Oxford). 2015 May;54(5):768-75
pubmed: 25667434
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Immunity. 2006 Dec;25(6):929-40
pubmed: 17137798
J Autoimmun. 2016 Apr;68:62-74
pubmed: 26898941
J Immunol. 2011 Mar 15;186(6):3299-303
pubmed: 21317389
Cereb Cortex. 2014 Dec;24(12):3289-300
pubmed: 23897647
J Neurosci. 2006 Jul 5;26(27):7234-44
pubmed: 16822981
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Cell Rep. 2018 Jul 17;24(3):577-584
pubmed: 30021156
Front Aging Neurosci. 2018 Jun 08;10:165
pubmed: 29937728
Nat Genet. 2018 Jan;50(1):73-82
pubmed: 29255264

Auteurs

Pilar López-Cotarelo (P)

Laboratorio de Investigación en Genética y Bases Moleculares de Enfermedades Complejas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.

Adela González-Jiménez (A)

Laboratorio de Investigación en Genética y Bases Moleculares de Enfermedades Complejas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.

Teresa Agudo-Jiménez (T)

Laboratorio de Investigación en Genética y Bases Moleculares de Enfermedades Complejas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Judith Abarca-Zabalía (J)

Laboratorio de Investigación en Genética y Bases Moleculares de Enfermedades Complejas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Yolanda Aladro (Y)

Neurology Department, Hospital Universitario de Getafe, Madrid, Spain.

Belén Pilo (B)

Neurology Department, Hospital Universitario de Getafe, Madrid, Spain.

Manuel Comabella (M)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Valld'Hebron (VHIR), Hospital Universitari Valld'Hebron, Universitat Autònoma, Barcelona, Spain.
Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.

Laura Espino-Paisán (L)

Laboratorio de Investigación en Genética y Bases Moleculares de Enfermedades Complejas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain. lauraep80@gmail.com.
Red Española de Esclerosis Múltiple (REEM), Madrid, Spain. lauraep80@gmail.com.

Elena Urcelay (E)

Laboratorio de Investigación en Genética y Bases Moleculares de Enfermedades Complejas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH